Target intelligence / Profile preview

Ribosomal 28S rRNA (28S rRNA)

Target
28S rRNA
Molecular classification
Ribosomal RNA, Nucleic acid
01

Overview

Ribosomal 28S rRNA is a fundamental structural and functional component of the eukaryotic 60S ribosomal subunit, playing a central role in the translation of messenger RNA into proteins. A highly conserved region known as the sarcin/ricin loop (SRL) is critical for the interaction with elongation factors EF-1 and EF-2, which facilitate the translocation step of protein synthesis. Mistletoe lectin A-subunit (ML-A), a Type II ribosome-inactivating protein (RIP) found in Viscum album, specifically targets this loop. ML-A functions as an N-glycosidase that removes a single adenine residue (A4324 in humans) from the SRL, leading to the irreversible inactivation of the ribosome. This halt in protein synthesis triggers cellular stress responses and leads to apoptosis. In therapeutic applications, particularly in complementary oncology, mistletoe extracts and recombinant lectins like aviscumine are used to exploit this mechanism to induce cell death in malignant cells and stimulate the immune system.

Other names
28S ribosomal RNASarcin/ricin loop of 28S rRNASRL of 28S rRNALarge subunit ribosomal RNA
02

Mechanism of action

The A-subunit of mistletoe lectin acts as a site-specific N-glycosidase that depurinates the adenine residue at position 4324 within the sarcin/ricin loop of the 28S rRNA, thereby preventing the binding of elongation factors and irreversibly inhibiting protein synthesis.

03

Biological functions

Protein synthesisTranslationRibosome assemblyPeptidyl transferase activity
04

Disease associations

CancerInfection
05

Safety considerations

Non-specific cytotoxicityImmunogenicity (anti-lectin antibodies)Injection site reactionsPotential for systemic toxicityAllergic reactions
06

Interacting drugs

Mistletoe lectin I

7 more in the full profile.

07

Biomarkers

Caspase-3 activation28S rRNA depurination levelsInhibition of protein synthesisAnnexin V staining

Beyond the preview

Go deeper on Ribosomal 28S rRNA (28S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal 28S rRNA (28S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call